ACKNOWLEDGING ADI IsletCore in your work
Congratulations on your manuscript! Proper acknowledgement of ADI IsletCore is important in order for us to continue to justify grant applications and requests for subsidies to support the program and keep user fees as low as possible. It is also important to acknowledge the organ procurement organizations for their tireless efforts in obtaining organs for our program and your research. We appreciate you using the following wording to acknowledge the use of materials provided by ADI IsletCore:
Human islets for research were provided by the Alberta Diabetes Institute IsletCore at the University of Alberta in Edmonton (http://www.bcell.org/adi-isletcore.html) with the assistance of the Human Organ Procurement and Exchange (HOPE) program, Trillium Gift of Life Network (TGLN), and other Canadian organ procurement organizations. Islet isolation was approved by the Human Research Ethics Board at the University of Alberta (Pro00013094). All donors' families gave informed consent for the use of pancreatic tissue in research.
If you’d like to cite the resource, we suggest:
Lyon J et al. (2016) Research-focused isolation of human islets from donors with and without diabetes at the Alberta Diabetes Institute IsletCore. Endocrinology, 157(2): 560-569.
Human islets for research were provided by the Alberta Diabetes Institute IsletCore at the University of Alberta in Edmonton (http://www.bcell.org/adi-isletcore.html) with the assistance of the Human Organ Procurement and Exchange (HOPE) program, Trillium Gift of Life Network (TGLN), and other Canadian organ procurement organizations. Islet isolation was approved by the Human Research Ethics Board at the University of Alberta (Pro00013094). All donors' families gave informed consent for the use of pancreatic tissue in research.
If you’d like to cite the resource, we suggest:
Lyon J et al. (2016) Research-focused isolation of human islets from donors with and without diabetes at the Alberta Diabetes Institute IsletCore. Endocrinology, 157(2): 560-569.